Search Results
Search
Filter by
Content Type
Client
Focus Area
Capability
Topic
-
How can we reduce the risk of cancer and support those diagnosed?
Enhancing the cancer research process
-
How NLP Expands the Power of Clinical Notes
February 25, 2026
Electronic health records (EHRs) can capture quantifiable aspects of patient care, such as diagnoses, prescriptions, imaging, and lab test results, all of which are essential…
-
Westat Experts Explore the Future of Quantum Computing
January 9, 2026
Westat experts joined other leading researchers, government innovators, industry partners, and students at Unlocking the Potential of Quantum Computing: A Symposium for the Quantum-Curious, hosted…
-
Westat Sponsors 2025 Quantum Computing Symposium at USG
November 17, 2025
Westat experts will participate in Unlocking the Potential of Quantum Computing: A Symposium for the Quantum-Curious, hosted by The Universities at Shady Grove (USG) on…
-
Improving Blood Transfusion Safety and Clinical Practices
November 4, 2025
Every 2 seconds, someone in the U.S. needs blood, platelets, or both. This translates to 16 million blood components transfused in patients annually. But how…
-
Holly Sawyer
Senior Research Associate
-
Novel Strategies Transform Clinical Trials Into Future Opportunities
October 1, 2025
For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to…
-
Real-World Insights: Nirsevimab’s Protection Against RSV in Infants
September 17, 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…
-
Mannshardt Joins NC State Advisory Board for New Data Science Graduate Program
September 10, 2025
Liz Mannshardt, PhD, Westat’s Vice President and Director of Statistics and Data Science, has been appointed to the External Advisory Board for North Carolina State…
-
RSV Antibody Provides Strong Infant Protection
August 26, 2025
New research has been published evaluating the effectiveness of nirsevimab, a long-acting monoclonal antibody recommended by the Centers for Disease Control and Prevention (CDC) in…
